The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens
This study has been completed.
Information provided by (Responsible Party):
University of California, Davis
First received: June 20, 2012
Last updated: June 21, 2012
Last verified: June 2012
The purpose of this study is to determine if the daily use of a certain amount and type of milk component for 2 months provides a significant stimulation to the immune system and specifically increases the chances of being protected against pneumonia after the vaccination.
To Evaluate the Effects of Milk Components (Whey and/or Inulin)
on the Response to Pneumococcal Vaccines in the Elderly.
||Observational Model: Case Control
Time Perspective: Retrospective
||The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens: A Randomized Placebo-controlled Clinical Trial
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||June 2008 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||60 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Healthy subjects > 60 years of age.
- Age and a willingness to participate
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||University of California, Davis
History of Changes
|Other Study ID Numbers:
|Study First Received:
||June 20, 2012
||June 21, 2012
||United States: Institutional Review Board
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 23, 2014
Respiratory Tract Diseases
Respiratory Tract Infections